Acolbifene () (developmental code names EM-652, SCH-57068) is a
nonsteroidal A nonsteroidal compound is a drug that is not a steroid nor a steroid derivative. Nonsteroidal anti-inflammatory drugs (NSAIDs) are distinguished from corticosteroids as a class of anti-inflammatory agents.
List of nonsteroidal steroid receptor mo ...
selective estrogen receptor modulator (SERM) which, as of 2015, is in
phase III clinical trial
Clinical trials are prospective biomedical or behavioral research studies on human participants designed to answer specific questions about biomedical or behavioral interventions, including new treatments (such as novel vaccines, drugs, diet ...
s for the treatment of
breast cancer
Breast cancer is cancer that develops from breast tissue. Signs of breast cancer may include a lump in the breast, a change in breast shape, dimpling of the skin, milk rejection, fluid coming from the nipple, a newly inverted nipple, or a r ...
.
See also
*
Acolbifene/prasterone
*
List of investigational sex-hormonal agents ยง Estrogenics
References
External links
Acolbifene - AdisInsight
Benzopyrans
Hormonal antineoplastic drugs
Phenols
1-Piperidinyl compounds
Selective estrogen receptor modulators
{{antineoplastic-drug-stub